RBF Capital, LLC - IMMUCELL CORP ownership

IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 29 filers reported holding IMMUCELL CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RBF Capital, LLC ownership history of IMMUCELL CORP
ValueSharesWeighting
Q4 2020$78,000
+9.9%
13,0860.0%0.01%
+50.0%
Q3 2020$71,000
+14.5%
13,0860.0%0.00%
-42.9%
Q2 2020$62,000
-6.1%
13,0860.0%0.01%
+16.7%
Q4 2019$66,000
-9.6%
13,0860.0%0.01%
-25.0%
Q3 2019$73,000
-14.1%
13,0860.0%0.01%
-11.1%
Q2 2019$85,000
+2.4%
13,0860.0%0.01%
-10.0%
Q1 2019$83,000
-9.8%
13,0860.0%0.01%
-16.7%
Q4 2018$92,000
-15.6%
13,0860.0%0.01%0.0%
Q3 2018$109,000
+21.1%
13,0860.0%0.01%
+9.1%
Q2 2018$90,000
-2.2%
13,0860.0%0.01%0.0%
Q1 2018$92,000
-20.0%
13,0860.0%0.01%
-15.4%
Q4 2017$115,00013,0860.01%
Other shareholders
IMMUCELL CORP shareholders Q1 2021
NameSharesValueWeighting ↓
Essex Financial Services, Inc. 23,776$89,0000.03%
SHUFRO ROSE & CO LLC 51,263$192,0000.02%
Tower Research Capital LLC (TRC) 254$1,0000.00%
Creative Planning 310$1,0000.00%
Renaissance Technologies 10,000$38,0000.00%
UBS AG 1,870$7,0000.00%
US BANCORP \DE\ 24$00.00%
BANK OF AMERICA CORP /DE/ 2,032$8,0000.00%
WELLS FARGO & COMPANY/MN 1$00.00%
MORGAN STANLEY 29,628$111,0000.00%
View complete list of IMMUCELL CORP shareholders